A two-week regimen of high-dose integrase inhibitors does not cause nephrotoxicity in mice
{{output}}
Background: The integrase inhibitors, raltegravir and dolutegravir, are nucleoside reverse transcriptase inhibitor-sparing agents which may be used as part of first-line antiretroviral therapy for HIV. These drugs inhibit creatin... ...
